Blood Gas and Electrolyte Analyzer Provides Results in 50 Seconds
|
By LabMedica International staff writers Posted on 09 Sep 2008 |
|
A new blood gas and electrolyte (BGE) analyzer provides high quality measurements in just 50 seconds including blood gases (pH, PCO2, PO2), electrolytes (Na+, K+, Ca++, Cl-), and hematocrit (Hct). From the measurements a number of parameters are additionally calculated, for instance, base excess (BE).
Roche Diagnostics (Basel, Switzerland) announced the launch of the cobas b 121 blood gas analyzer in the EMEA region (Europe, Middle East, Africa), Asian, and Latin American markets. The cobas b 121 system meets expectations for a low cost, effective instrument for the rapid determination of blood gases and electrolytes.
The system supports clinical laboratories in facing the challenge of increasing cost pressure on healthcare. High levels of automation and low levels of maintenance mean very little operator intervention. This combined with its economy mode, maintenance-free, long-life sensors, and reusable waste bottles help to save costs.
The already existing cobas b 121 platform was simplified and reduced to the analytes needed for the rapid determination of blood gas and electrolytes status as well as acid base disorders. Although the complexity has been reduced on the system, it has kept the touch screen interface and high levels of on-board data management and connectivity. Customers currently using separate analyzers for blood gas and electrolyte measurements can now consolidate blood gases and electrolytes on one analyzer for greater efficiency.
The instrument is one of the fastest BGE systems for medium to high throughput (30 samples per hour) situations, and the maintenance-free sensors and high volume, reusable reagent bottles make it easy to operate and reliable. Calibrations are run automatically with a liquid calibration system, making it entirely gas-free.
Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. Roche is a world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders, and diseases of the central nervous system.
Related Links:
Roche Diagnostics
Roche Diagnostics (Basel, Switzerland) announced the launch of the cobas b 121 blood gas analyzer in the EMEA region (Europe, Middle East, Africa), Asian, and Latin American markets. The cobas b 121 system meets expectations for a low cost, effective instrument for the rapid determination of blood gases and electrolytes.
The system supports clinical laboratories in facing the challenge of increasing cost pressure on healthcare. High levels of automation and low levels of maintenance mean very little operator intervention. This combined with its economy mode, maintenance-free, long-life sensors, and reusable waste bottles help to save costs.
The already existing cobas b 121 platform was simplified and reduced to the analytes needed for the rapid determination of blood gas and electrolytes status as well as acid base disorders. Although the complexity has been reduced on the system, it has kept the touch screen interface and high levels of on-board data management and connectivity. Customers currently using separate analyzers for blood gas and electrolyte measurements can now consolidate blood gases and electrolytes on one analyzer for greater efficiency.
The instrument is one of the fastest BGE systems for medium to high throughput (30 samples per hour) situations, and the maintenance-free sensors and high volume, reusable reagent bottles make it easy to operate and reliable. Calibrations are run automatically with a liquid calibration system, making it entirely gas-free.
Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. Roche is a world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders, and diseases of the central nervous system.
Related Links:
Roche Diagnostics
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Rapid Molecular Testing Device
FlashDetect Flash10
Latest Clinical Chem. News
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
- Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
- Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
Channels
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Microbiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more
Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
